Whitehawk Therapeutics, Inc. (WHWK)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Whitehawk Therapeutics, Inc. reported revenue of $7.14M, down 72.5% from the prior year. The company ran a net loss, with a net margin of -288.3%. It held $150.83M in total assets against $14.52M in total liabilities.
Key ratios (FY2025)
-1601.1%
Operating margin
-288.3%
Net margin
-15.1%
Return on equity
-72.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.14M | $25.98M | $24.35M | $15.22M | $14.00M | $14.00M | $0 | $20.16M | — | — |
| Cost of Revenue | $760.0K | $3.02M | $2.81M | $1.33M | $0 | — | — | — | — | — |
| Operating Income | -$114.40M | -$67.46M | -$71.93M | -$62.68M | -$111.22M | -$2.55M | -$24.44M | -$11.18M | -$21.39M | -$16.63M |
| Net Income | -$20.60M | -$63.69M | -$65.77M | -$60.51M | -$110.09M | -$3.48M | -$23.27M | -$10.40M | -$21.40M | -$16.98M |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | — | — | — | — | — |
| Total Assets | $150.83M | $70.32M | $132.42M | $184.24M | $157.91M | $18.82M | $39.94M | $64.12M | $21.03M | $2.40M |
| Total Liabilities | $14.52M | $17.84M | $27.23M | $25.86M | $21.50M | $31.26M | $3.40M | $5.46M | — | — |
| Shareholders' Equity | $136.31M | $52.48M | $105.19M | $158.38M | $136.41M | -$12.43M | -$9.09M | $58.67M | $17.44M | -$86.22M |
| Cash & Equivalents | $37.57M | $28.67M | $62.89M | $39.02M | $148.99M | $4.46M | $38.52M | $62.61M | $20.26M | $1.61M |
| Operating Cash Flow | -$97.43M | -$59.55M | -$59.66M | -$49.64M | -$22.42M | -$12.70M | -$23.85M | -$5.81M | -$18.88M | -$24.5K |
| Capital Expenditures | $552.0K | $1.65M | $3.97M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | $8.9K | $113.3K |
| Shares Outstanding | 47.15M | 24.68M | 24.55M | 24.44M | 20.89M | 2.54M | 40.59M | 40.59M | 27.07M | 1.24M |